SCM
PRTA icon

Soleus Capital Management’s Prothena Corp PRTA Stock Holding History

Soleus Capital Management’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-674,603
Closed -$7.06M – 71
2020
Q2 		$7.06M Buy
+674,603
New +$7.5M 4.02% 6

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Soleus Capital Management's PRTA Position: Q3 2020 in Review

Soleus Capital Management sold out of Prothena Corp (PRTA) in Q3 2020, closing a stake of 674,603 shares — an estimated $7.06M sold.

Soleus Capital Management first reported a position in PRTA in Q2 2020 and held it in 1 quarter. The position peaked at $7.06M in Q2 2020. 140 funds tracked by Wall St. Rank hold PRTA as of Q3 2020.

  • Soleus Capital Management reported no remaining Prothena Corp position as of Q3 2020 after selling out during the quarter.
  • Soleus Capital Management sold 674,603 Prothena Corp shares in Q3 2020, an estimated $7.06M.
  • Soleus Capital Management first reported a position in Prothena Corp in Q2 2020 and held it in 1 quarter.
  • Soleus Capital Management's Prothena Corp position peaked at $7.06M in Q2 2020.
  • 140 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2020.

Based on Soleus Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.